Adedayo A. Onitilo, MD, MSCR, FACP

Articles by Adedayo A. Onitilo, MD, MSCR, FACP

Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study

ByKatrina A.B. Goddard, PhD,Erin J. Aiello Bowles, MPH,Heather Spencer Feigelson, PhD, MPH,Laurel A. Habel, PhD,Sharon Hensley Alford, PhD,Catherine A. McCarty, PhD, MPH,Larissa Nekhlyudov, MD, MPH,Adedayo A. Onitilo, MD, MSCR, FACP,Alanna K. Rahm, PhD, MS,Jennifer A. Webster, MS

Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.

Latest Updated Articles



Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text